Thomas Russo
Director of Finance/CFO at ICOSAVAX, INC.
Thomas Russo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ICOSAVAX, INC. | Director of Finance/CFO | 2021-05-31 | - |
Career history of Thomas Russo
Former positions of Thomas Russo
| Companies | Position | Start | End |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Comptroller/Controller/Auditor | 2019-10-27 | 2021-06-03 |
| Director of Finance/CFO | 2019-10-27 | 2021-06-03 | |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2012-09-30 | 2019-09-30 |
Robert W. Baird & Co., Inc. (Broker)
 Robert W. Baird & Co., Inc. (Broker) Investment Banks/BrokersFinance Robert W. Baird & Co., Inc. (Broker) (Baird-Broker) is the broker-dealer division of Robert W. Baird & Co., Inc., an investment bank and financial services company headquartered in Milwaukee, Wisconsin. The firm was founded in 1919 and is ultimately owned by Baird Financial Group, Inc. Baird-Broker offers a full suite of comprehensive trading services for institutional clients. | Analyst-Equity | 2003-12-31 | 2012-09-30 |
Training of Thomas Russo
| University of Notre Dame | Undergraduate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Statistics
International
| United States | 7 |
Operational
| Director of Finance/CFO | 2 |
| Comptroller/Controller/Auditor | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| GILEAD SCIENCES, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Robert W. Baird & Co., Inc. (Broker)
Robert W. Baird & Co., Inc. (Broker) Investment Banks/BrokersFinance Robert W. Baird & Co., Inc. (Broker) (Baird-Broker) is the broker-dealer division of Robert W. Baird & Co., Inc., an investment bank and financial services company headquartered in Milwaukee, Wisconsin. The firm was founded in 1919 and is ultimately owned by Baird Financial Group, Inc. Baird-Broker offers a full suite of comprehensive trading services for institutional clients. | Finance |
Icosavax, Inc.
 Icosavax, Inc. Pharmaceuticals: MajorHealth Technology Icosavax, Inc. engages in the development and commercialization of vaccines against infectious diseases. It focuses on developing vaccine candidates for viral causes of pneumonia in older adults. The company was founded by Neil King and David Baker on November 1, 2017 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Thomas Russo
- Experience
